Subjective perception versus objective outcome after intravitreal ranibizumab for exudative AMD
Authors:
- 8 September 2011
- journal article
- retinal disorders
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 250 (2) , 201-209
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2011
- Central Retinal Artery Occlusion: Local Intra-arterial Fibrinolysis versus Conservative Treatment, a Multicenter Randomized TrialOphthalmology, 2010
- Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age‐related macular degenerationActa Ophthalmologica, 2010
- Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography studyBritish Journal of Ophthalmology, 2009
- Relationship Between Optical Coherence Tomography Retinal Parameters and Visual Acuity in Neovascular Age-Related Macular DegenerationOphthalmology, 2008
- Quantitative Subanalysis of Optical Coherence Tomography after Treatment with Ranibizumab for Neovascular Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2008
- Reliability Testing of the Dutch Version of the Radner Reading ChartsOptometry and Vision Science, 2008
- Reproducibility of Quantitative Optical Coherence Tomography Subanalysis in Neovascular Age-Related Macular DegenerationInvestigative Ophthalmology & Visual Science, 2007
- Subjektives Empfinden nach intravitrealer Bevacizumab-InjektionKlinische Monatsblätter für Augenheilkunde, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006